TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/26 17:35 | 2/27/26 | AUPH | Aurinia Pharmaceuticals Inc. | Health | Drug | Pharmaceutical Preparations | Tang Kevin | CA | D | P.m | 12,689 | 14.10 | 0 | 900 | 8 | 12,230 | I | ||||||||||||||||
8/5/25 17:31 | 8/1/25 | AUPH | Aurinia Pharmaceuticals Inc. | Health | Drug | Pharmaceutical Preparations | Tang Kevin | CA | D | P.m | 13,590 | 10.45 | 0 | 1,300 | 13 | 11,330 | I | ||||||||||||||||
3/4/25 17:03 | 2/28/25 | AUPH | Aurinia Pharmaceuticals Inc. | Health | Drug | Pharmaceutical Preparations | Tang Kevin | CA | D | P.m | 12,713 | 7.95 | 0 | 1,600 | 19 | 10,030 | I | ||||||||||||||||
12/9/24 16:52 | 12/5/24 | AUPH | Aurinia Pharmaceuticals Inc. | Health | Drug | Pharmaceutical Preparations | Tang Kevin | CA | D | P.m | 10,822 | 9.02 | 0 | 1,200 | 17 | 8,430 | I | ||||||||||||||||
9/18/24 16:31 | 9/16/24 | OMIC | Singular Genomics Systems, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Tang Kevin | CA | T | P.m | 1,806 | 14.75 | 0 | 122 | 49 | 372 | I | |||||||||||||||
10/13/23 16:57 | 10/11/23 | RAIN | Rain Oncology Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tang Kevin C | CA | T | P.m | 279 | 0.9820 | 0 | 284 | 8 | 4,024 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |